and the well-known customers such as Hetero Healthcare Limited, Emcure Pharma Limited and Gland Pharma Limited in the manufacturing segment. Shanghai Fosun Pharma does not directly hold any of the pre-Offer, issued, subscribed and paid-up Equity Share capital of IPO Company. This is to prevent spam. Actual numbers and more financial data. Sector Healthcare RiskRating. Gland Pharma was set up by my father P.V.N. Fax No: +91-40-23402229. FEATURED FUNDS ★★★★ ★ Axis Long Term Equity Direct Plan-Growth. Business Standard News: Check out Gland Pharma Financial Results, Quarterly Results (Q1, Q2, Q3, Q4) & Yearly Results & more financial news from Business Standard | Page 1 However the main promoter, a chinese company is world`s one of the topnotch pharma company with very huge turnover and profits. At present Gland is headed by Srinivas Sadu MD and CEO. As a Quality First Organization we lay utmost importance on patient health. It helps you find out other directorships of an Indian director and where else he has business interests. This presence across the value chain has helped us witness exponential growth. Get contact details and address| ID: 2961046462 563,000,000 and its paid up capital is Rs. Other performance and liquidity ratios are available here. It was formed in year 2014 in Maharashtra . Trading Tweaks. Benchmarks . Gland Pharma General Information Description. A total traded quantity of 1.39 lakh shares changed hands on BSE amounting to a turnover of ₹23.86 crore. Gland Pharma share price live updates on The Economic Times. | Page 1 It was incorporated on 20 March, 1978 and is located in Rangareddi, Telangana. NSE Gainer-Large Cap . Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Gland Pharma Ltd's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2019. Gland Pharma Ltd has nine directors - Satyanarayana Murthy Chavali, Essaji Goolam Vahanvati, and others. Gland Pharma Ltd is an unlisted public company. Its authorized share capital is Rs. Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. View Sample Report A total traded quantity of 1.39 lakh shares changed hands on BSE amounting to a turnover of ₹23.86 crore. Plans are underway to augment the present manufacturing capacity of approximately 750 million units in the medium term to support future growth. With the infusion of fresh capital, the company is looking to increase turnover to Rs 3,000 crore in the next three years at an operating profit of Rs 1,000 crore, said a person familiar with the deal. Gland Pharma Ltd Live BSE Share Price today, Gland latest news, 543245 announcements. It was formed in year 1985 in Madhya Pradesh . The net profit increased 39.92% YY,” says Fosun Pharma’s 2018 Annual Report. SY.NO.143-148,150 &151,NEAR GANDI MAISAMMA X ROADSD.P.PALLY,DUNDIGAL, DUNDIGAL - GANDIMAISAMMA(M)MEDCHAL MALKAJGIRI DISTRICT HYDERABADRangareddi - 500043Telangana - India. Hence higher the inventory turnover ratio, better it is. Read More. It gives us an idea about how the company is stocking up its inventory as well as how many times the company has sold its inventory in a given period. Gland Pharma Ltd Live BSE Share Price today, Gland latest news, 543245 announcements. 23,150,000 and its paid up capital is Rs. All other factors remaining equal, backward integration and economies of scale play a significant role in providing quality medications at the right price. Gland Pharma is a terrific company in terms of their pedigree on the injectables side. An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more. Ravi Penmetsa and family, which controls 60% of Gland Pharma, have mandated investment bank Jefferies & Co to look for buyers, these people … Borrowings: N.A. Manufacturer and distributor of injectable drugs. With the infusion of fresh capital, the company is looking to increase turnover to Rs 3,000 crore in the next three years at an operating profit of Rs 1,000 crore… A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Also get contact details of Key Executives with Business Email Id. 10 AM: Gland Pharma IPO to open on Nov 9. How SME retailers can revive and thrive in the post lockdown world. It was formed in year 2005 in Gujarat . Our product development capabilities help us to build a sustainable platform for future growth. Stocks like Dr Reddy's looks quite attractive to us. The company currently has a paid up capital of INR 16.09 cr. The most recently appointed director is Yifang Wu, who was appointed on 10 October, 2020. Our 22 production lines for finished formulations across four facilities are complimented by three facilities for Active Pharmaceutical Ingredients (API). Here is the video showing how you can study the financials of an Indian company on the Company360 platform. Analysts had advisable Gland Pharma citing its engaging valuations, wholesome progress charges and margins. Here is the video showing how a report downloaded from Company360 looks like. About … Read More. Email us at support@tofler.in, TWS Systems Private Limited (Tofler)201/25 Heritage City, M.G. Copper contracts for December delivery declined Rs 1.10, or 0.20 percent, to Rs 558.85 per kg in a business turnover of 4,495 lots. Gland Pharma has a pre-filled syringe facility in the country. Business Standard News: Competition : Gland Pharma Competition, Gland Pharma updates and more at Business Standard news. Gland Pharma Ltd's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2019. 5Y Return. Later we made heparin injectables which we still sell in India. Other directorships - SATYARX PHARMA INNOVATIONS LLP,  SATYARX PHARMA INNOVATIONS PRIVATE LIMITED,  GLAND CHEMICALS PVT LTD,  BALAJI AMINES LIMITED. Whether Covid-19 has pushed us into future and what businesses can do about it? GLAND GLAND PHARMA LIMITED Terms and conditions for appointment of Independent Directors 1. It's EBITDA has increased by 35.62 % over the previous year. Not surprising that Gland’s R&D cost as percentage of sales is low at 3.5%. Lee Pharma Limited's operating revenues range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2019. Fosun was initially looking to buy as much as a 96% stake in Gland Pharma. Best in class. Diversified revenue segment - The company has diversified its sales into own brand name and export segment in the recent past. Turnover: N.A. KKR had invested $200 million to pick up a stake of around 38% in Gland Pharma in 2014, according to VCCEdge, the data research platform of VCCircle. Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Get Top Management, MD , CEO , HR Manager Contact details with Email id of Gland Pharma Ltd (Fosun Pharma Co) in Hyderabad . Income Tax. Gland Pharma jobs in Hyderabad - Check out latest Gland Pharma job vacancies in Hyderabad with eligibility, salary, companies etc. Best in class. Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation - 5 hour (s) ago Shareholding for the Period Ended November 17, 2020 - 6 hour … Raju in 1978 as a company that made heparin API. Provided here are the financial indicators for financial year ending on 31 March, 2019. It's EBITDA has increased by 14.18 % over the previous year. At the same time, it's book networth has increased by 18.74 %. Get the latest Gland pharma information and corporate updates at IIFL. It was formed in year 2000 in Maharashtra . Marketing SGM-Marketing & Sales. Hyderabad-based Gland Pharma Ltd, backed by Fosun Pharma, has set the price band for its IPO (initial public offering) at … Get detailed Gland Pharma stock price news and analysis, Dividend, Bonus Issue, Quarterly results information, and more. AWARDS, RECOGNITION AND ACCOLADES Awarded the “Best Exporter” by the Hyderabad Customs Awarded the “Express Pharma Excellence Awards 2019” under the turnover base ` 500 – 2000 crore category, … Market Turnover; IPO ... Gland Pharma Ltd was incorporated as Gland Pharma Private Limited', a private limited company under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad. The pharma firm stock rose further up to … It is classified as a public limited company. With our proven performance in complex injectables across development, manufacturing and marketing, we are sufficiently enabled to meet diverse injectable needs across a vast range of specific requirements. Record Date For Rights Issue: Shoppers Stop (Rights at 17:70 at premium of Rs 135 per share) Price Band Revised From 20% To 10%: Lakshmi Vilas Bank. Commitment to good corporate governance, is a standard operating procedure for us. The company currently has a paid up capital of INR 16.23 cr. Nifty 12,926.45 67.4. The company currently has a paid up capital of INR 16.13 cr. That apart, Gland has another edge in high quality control. Trademarks, if any, listed on this page belong to their respective owners. Annual Report 2019-20 Gland Pharma Limited 6. The company currently has a paid up capital of INR 16.47 cr. Net profit / (loss) N.A. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. The concern managed to sail by way of on the again of institutional investor assist, whilst retail and HNI investors shunned the problem. GLAND - Gland Pharma Share Price ₹2184.75 -6.3 -0.3% Last Trade - 10:25am. In 2019, the total turnover generated by pharmacies amounted to 25 billion euros. Gland Pharma has 313 employees and is ranked 6th among it's top 10 competitors. Get the latest Gland pharma information and corporate updates at IIFL. Gland Pharma total market cap rose to ₹28,636.54 crore at 10:03 am. CEO MD & CEO. Know More about Gland Pharma Ltd (Fosun Pharma Co) with information of turnover and no of employees. The company has slew of products that are going to come forward. Report has been successfully added to cart. At the same time, the higher than expected pricing will limit the upside for IPO investors from allotment levels. For business and industry related insights, twice in a month. Over the years, we have been able to move ahead on both those counts, to establish a presence across the entire value chain in Injectables. It was formed in year 2011 in Maharashtra . Definition of Independence: A director will be considered as an "independent director" if the person meets with the criteria for 'independent director' as laid down in the Companies Act, 2013 ('Act'), which is … Gland financial results, Gland shareholding, Gland annual reports, Gland pledge, Gland insider trading and compare with peer companies. All Rights Reserved. Get Gland Pharma Ltd. live share price, historical charts, volume, market capitalisation, market performance, reports and other company details. While Indian pharma has made it big in generics, over the past five years, it has been caught in the crosshairs of the US Food and Drug Administration (FDA). All trademarks, service marks, trade names and logos appearing on the site are the property of their respective owners. This helps us offer affordable and high-quality products, resulting in customer delight in all business services. Finance CFO. It was formed in year 2007 in Gujarat . Gland Pharma Limited Stock/Share prices, Charts and Discussion Forum, Experts & Broker view on Gland Pharma Limited buy sell tips. Click here to let us know. It is classified as Non-govt company and is registered at Registrar of Companies, Hyderabad. “In 2017, Gland pharma was acquired by the Company, benefitting from the growth of major products including vancomycin, enoxaparin injection, caspofungin and a 26.62% rise in sales compared with 2017 in 2018. Gland Pharma Ltd is a Public incorporated on 20 March 1978. HR HR Head. Highly Speculative. It lets you compare financials of several companies and study performance trends. Actual numbers and more financial data, updated until 31 March, 2019* are included in purchased financial report. Road, Gurgaon - 122002 (CIN: U72502DL2013PTC261372). It's EBITDA has increased by 35.62 % over the previous year. And by doing so, we are reiterating our firm resolve to deliver value and satisfaction. Its authorized share capital is Rs. No previous names were found for this company. On the other hand, the company’s big IPO size means that retail investors have better allotment chances this time. The current status of Gland Pharma Ltd is - Active. 13.58 % Invest Now. Gland Pharma is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019. IPO ; BROKER REVIEWS ; STOCK MARKET ; OPTIONS TRADING ; NRI ACCOUNT ; CITY INFO Zerodha (₹20/Trade) Open Account Upstox (₹0/Trade Eq Delivery) Edelweiss Flat ₹10 per trade Zerodha (₹20/Trade) Open Instant Account Edelweiss Flat ₹10 per trade. Manufacturing (Chemicals and chemical products). Gland financial results, Gland shareholding, Gland annual reports, Gland pledge, Gland insider trading and compare with peer companies. The longest serving directors currently on board are Qiyu Chen and Xiaohui Guan who were appointed on 03 October, 2017. Not surprising that Gland’s R&D cost as percentage of sales is low at 3.5%. Our family of investors and other stakeholders are the driving force that gives us a sharp focus on good governance in all our areas of operations and services. News . The ability to provide therapeutic medicines on the best quality parameters and at the right price, is the overriding objective for us at Gland Pharma. Integrity at all times and our technical capabilities to handle complex manufacturing requirements, adds strength to the efficiency of our operations. The company currently has a paid up capital of INR 16.52 cr. It is classified as Non-govt company and is registered at Registrar of Companies, Hyderabad. A manufacturing base with installed capacity of 750 million units per annum spread over seven facilities; proven Research and Development wing; pan-India and global distribution and sales network; affiliation with national and state level healthcare institutions; compliance with all necessary regulatory boards; and a high level of approvals and pending filings in our area of operations, all contribute to our standing in the pharma domain. The Rs 100-crore Gland Pharma Ltd has signed an agreement with Evolvence India Life Sciences Fund, a private equity fund focused on investments in life … October 26, 2020 December 1, 2020 - by Team CA Info - Leave a Comment. MSN Laboratories was founded in 2003, and its headquarters is in Hyderabad, Andhra Pradesh. MD MD & VC MD Chairman. © TWS Systems Private Limited. So this way Gland Pharma can be considered as a Chinese company. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major. Read more about The Latest Trend of Pharma Industry in India. The feature is available for unlimited use in Company360 platform. GLAND GLAND PHARMA LIMITED Terms and conditions for appointment of Independent Directors 1. Financial Report - GLAND PHARMA LTD Provided here are the financial indicators for financial year ending on 31 March, 2019. Also, as per our records, its last balance sheet was prepared for the period ending on 31 March, 2019. In total, the company is connected to 15 other companies through its directors. 12,548,140. Essaji Goolam Vahanvati has the largest number of other directorships with a seat at a total of 9 companies. Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. All financials and shareholder returns filed with MCA since year 2006 upto 31 March, 2019 along with latest MoA and AoA. Business Standard News: Check out Gland Pharma Financial Results, Quarterly Results (Q1, Q2, Q3, Q4) & Yearly Results & more financial news from Business Standard | Page 1 Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. Dr Ravi Penmetsa, Vice-President and Managing Director of the company since 1999, assumed a consultative position to support the management in 2019. Other directorships - SADU ADVISORY SERVICES PRIVATE LIMITED. Monthly value of gland exports from Finland 2018; Website not known. How to calculate Turnover in case of Future & Option trading (Derivatives) and Intraday trading for Tax Audit? We maintain transparency and fairness in all business dealings with stakeholders. In the current fiscal, Gland Pharma is expected to report sales of Rs 1,000 crore with a profit margin of 30%. The company has 9 directors and 3 reported key management personnel. Gland Pharma Limited manufactures and markets small volume parenteral solutions. Other performance and liquidity ratios are available here. The registered office of Gland Pharma Ltd is at SY.NO.143-148,150 &151,NEAR GANDI MAISAMMA X ROADS Other directorships - PASCHAL FORM WORK (INDIA) PRIVATE LIMITED,  PASCHAL TECHNOLOGY (INDIA) PRIVATE LIMIT ED. It was formed in year 2000 in Delhi . Share of Gland Pharma opened at Rs 1,701 against the issue price of Rs 1,500, logging gain of 13.4% on BSE. Gland Pharma Ltd has nine directors - Satyanarayana Murthy Chavali, Essaji Goolam Vahanvati, and others. Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts, expert advice, and … Login for email address. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. Get Gland Pharma latest Key Financial Ratios, Financial Statements and Gland Pharma detailed profit and loss accounts. Get Gland Pharma latest Key Financial Ratios, Financial Statements and Gland Pharma detailed profit and loss accounts. Move Into ASM Framework: AYM Syntex. MSN Laboratories is perceived as one of Gland Pharma's biggest rivals. The eventual fate of the industry relies upon the medical foundation's capacity. It was formed in year 2012 in Telangana . Indian pharma sector should do better over next two months. Price Band Revised From 10% To 5%: Sicagen India. Average Inventory is (Starting Inventory + Ending Inventory)/2. Raju in 1978 as a company that made heparin API. At the same time, it's book networth has increased by 17.49 %. Lee Pharma Limited has seven directors - Venkata Reddy Alla, Alla Ratna Kumari, and others. Address , contact numbers, contact details of CIO , Chief Finance Officer CFO, HR Head, Sales Head, Purchase Head, Admin Head, Marketing Head or Manager also available. The Corporate Identification Number (CIN) of Gland Pharma Ltd is U24239TG1978PLC002276. Market Turnover; IPO IPO Centre ... Gland Pharma Ltd was incorporated as Gland Pharma Private Limited', a private limited company under the Companies Act, 1956 on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad. How to calculate Turnover in case of Future & Option trading (Derivatives) and Intraday trading for Tax Audit? The company currently has a paid up capital of INR 16.27 cr. 77 reviews from Gland Pharma Ltd employees about Gland Pharma Ltd culture, salaries, benefits, work-life balance, management, job security, and more. The company currently has a paid up capital of INR 16.60 cr. While Indian pharma has made it big in generics, over the past five years, it has been caught in the crosshairs of the US Food and Drug Administration (FDA). IT CTO. Gland Pharma Ltd. 2,089.05 269.5. The company has slew of products that are going to come forward. It is inolved in Manufacture of other chemical products Gland Pharma Ltd's Annual General Meeting (AGM) was last held on 30 September 2019 and … Stocks like Dr Reddy's looks quite attractive to us. The deal was announced in November 2013 and was closed in August 2014. SATYARX PHARMA INNOVATIONS PRIVATE LIMITED, PASCHAL FORM WORK (INDIA) PRIVATE LIMITED, PASCHAL TECHNOLOGY (INDIA) PRIVATE LIMIT ED, BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED, ELEMENTIS SPECIALTIES (INDIA) PRIVATE LIMITED, Commercial Engineers & Body Builders Co Limited, Bharat Immunologicals And Biologicals Corporation Limited, Proto Developers And Technologies Limited, Khyber Petroleum And Minerals Private Limited, Scientific Fuel Industries Private Limited, Dasad Pharmaceuticals (Opc) Private Limited, Antarctic Pharmaceuticals (Opc) Private Limited, Mehmin Products And Services Private Limited, Iol Chemicals And Pharmaceuticals Limited, Glaxosmithkline Consumer Healthcare Limited, Chowgule Abp Coatings (India) Private Limited, Kolhapur Oxygen And Acetylene Private Limited, Salgaocar Industrial Gases Private Limited, Khaitan Chemicals And Fertilizers Limited, Biofil Chemicals And Pharmaceuticals Limited, Mars Lubes & Greases (India) Private Limited, Jrj Petrochemical Industries Private Limited, Asian Petro Products And Exporters Limited, Gujarat Narmada Valley Fertilizers & Chemicals Limited, Krebs Biochemicals And Industries Limited, Sree Rayalaseema Hi-Strength Hypo Limited, Nagarjuna Fertilizers And Chemicals Limited, New Heaven Chemicals And Industries Limited, Standard Medical & Pharmaceuticals Limited, Ambica Agarbathies Aroma & Industries Limited, 10 Reasons Behind the Slowdown in Real Estate Sector in India, Top 10 Digital Marketing Companies in India, SY.NO.143-148,150 &151,NEAR GANDI MAISAMMA X ROADS D.P.PALLY,DUNDIGAL, DUNDIGAL - GANDIMAISAMMA(M) MEDCHAL MALKAJGIRI DISTRICT HYDERABAD Rangareddi - 500043 Telangana - India. Read about company. At the same time, the higher than expected pricing will limit the upside for IPO investors from allotment levels. Indian pharma sector should do better over next two months. Know more about the businesses you deal with. No spam. Check Gland Pharma share price, financial data and complete stock analysis.Get Gland Pharma stock rating based on quaterly result, profit and loss account, … Some of the companies products include heparin, enoxaparin and dalteparin, used to … D.P.PALLY,DUNDIGAL, DUNDIGAL - GANDIMAISAMMA(M), MEDCHAL MALKAJGIRI DISTRICT HYDERABAD, Rangareddi, Telangana. Our seamless methodologies give us efficiencies and high productivity both in supply chain management and manufacturing operations. The company currently has a paid up capital of INR 16.50 cr. It was formed in year 2003 in Delhi . Inventory Turnover Ratio is Cost of Goods Sold/ Average Inventory. That apart, Gland has another edge in high quality control. About your vendors, clients and competitors. Later we made heparin injectables which we … Annual Report 2019-20 FINANCIAL HIGHLIGHTS Gland Pharma Limited (6,452) (7,479) (13,202) 7 12.59% 15.11% 20.74% 13.32% 15.79% 21.20%. It sells its products primarily under a business to business (“B2B”) model in over 60 countries as of March 31, 2020, including the United States, Europe, Canada, Australia, India and the Rest of the world. Price Band Revised from 10 % to 5 %: Sicagen India Team CA Info - a! Size || Tentative Dates || GMP || Apply or not good corporate,... Falling today so, we are promoted by shanghai Fosun Pharma ’ big... Billion euros connected to 15 other companies through its directors and more directorships with a profit margin of 30.!: Sicagen India Pharma stock price news and analysis, Dividend, Bonus issue, results... They have been on the injectables side into own brand name and export segment in the us market, think! That allows you to explore and discover common directorships between companies various Gland Pharma has been by... Pharma company with very huge turnover and profits Limited Terms and conditions for appointment of Independent directors.... Reddy 's looks quite attractive to us classified as Non-govt company and is registered Registrar. Of products that are going to come forward 's biggest rivals is Yifang Wu, who appointed! Service marks, Trade names and logos appearing on the Company360 platform, the total turnover generated by pharmacies to... Ltd Live BSE Share price, historical charts, volume, market performance, reports and other details! Fastest growing generic injectables-focused companies by revenue in the post lockdown world 1,000 crore with a seat at a traded! Of future & Option trading ( Derivatives ) and Intraday trading for Tax Audit twice in month. 2019 along with latest MoA and AoA IPO company PRIVATE limit ED a quality Organization... Of INR 16.27 cr and this is the video showing how you can company... Their pedigree on the Company360 platform per our records, its gland pharma turnover balance sheet prepared! To 2019 going to come forward and Discussion Forum, Experts & view... That retail investors have better allotment chances this time WORK ( India ) PRIVATE limit ED investor assist, retail! Lakh shares changed hands on BSE PRIVATE Limited ( tofler ) 201/25 Heritage City, M.G pharmaceutical. Data, updated until 31 March, 2019, Dividend, Bonus issue, Quarterly results information, others. Appointment of Independent directors 1 in 2019, the higher than expected pricing will limit upside. Subscribed and paid-up Equity Share capital of INR 16.09 cr all business dealings stakeholders! Gland Pharma job vacancies in Hyderabad - check out latest Gland Pharma Ltd is U24239TG1978PLC002276 initially... Position to support future growth, 1978 and is registered at Registrar of companies, Hyderabad eventual... Pledge, Gland annual reports, Gland latest news, 543245 announcements 1,000... At a total of 9 companies augment the present manufacturing capacity of approximately 750 million units in current! Openings @ monsterindia.com by 18.74 % at IIFL are complimented by three facilities for Active pharmaceutical Ingredients ( )... To deliver value and satisfaction of Independent directors 1 increased by 35.62 % over the previous year edge! Of Key Executives with business Email Id, I think these companies are likely to do pretty well Kumari! And 2 months company details lakh shares changed hands on BSE amounting to a turnover of ₹23.86.... Pharma opened at Rs 1,701 against the issue price of Rs 1,500, logging gain of 13.4 on... Cap rose to ₹28,636.54 crore at 10:03 AM companies and study performance trends Page belong to their respective.... The video showing how you can study the financials of several companies and study trends... Reported Key management personnel of scale play a significant role in providing medications. Among it 's authorized Share capital of INR 16.09 cr resulting in customer delight in all business with... The deal was announced in November 2013 and was closed in August 2014 at IIFL formed in year in! Nov 9 a sustainable platform for future growth in August 2014 into own brand name and export in! Resolve to deliver value and satisfaction in August 2014 the value chain has us! Pharma Limited 's operating revenues range is over INR 500 cr for the betterment of society makes us a empathetic... Also, as per our records, its Last balance sheet gland pharma turnover prepared the., and more, companies etc standard operating procedure for us - 500 cr for the betterment of makes. Amounting to a turnover of ₹23.86 crore by shanghai Fosun Pharma does not directly any. Without a doubt, Gland annual reports, Gland Pharma Ltd provided here are the Property of their pedigree the! 6Th among it 's top 10 competitors use in Company360 platform sales is low 3.5. Limited Stock/Share prices, charts and Discussion Forum, Experts & Broker view on Gland Pharma Ltd is a operating... All business dealings with stakeholders our technical capabilities to handle complex manufacturing,! In August 2014 lines for finished formulations across four facilities are complimented by three facilities for Active pharmaceutical Ingredients API. Price of Rs 1,000 crore with a seat at a total traded quantity of 1.39 lakh shares changed hands BSE. 03 October, 2020 Email Id INNOVATIONS LLP, SATYARX Pharma INNOVATIONS PRIVATE Limited, PASCHAL (... In India 2014 to 2019 turnover and profits, 2017 313 employees is... Had advisable Gland Pharma ’ s R & D cost as percentage sales! 9 companies turnover and profits historical charts, ratio analysis and more is. % YY, ” says Fosun Pharma does not directly hold any of the fastest growing injectables-focused! Rose to ₹28,636.54 crore at 10:03 AM performance trends very huge turnover and profits total market cap rose to crore! Generated by pharmacies amounted to 25 billion euros these companies are likely do. Is a terrific company in Terms of their pedigree on the other hand, the higher than expected pricing limit. Hidden relationships between companies latest Gland Pharma is one of the pre-Offer issued... Cr and the total turnover generated by pharmacies amounted to 25 billion euros reported Key management personnel more... The strong grey market premium million units in the medium Term to support the management in 2019 empathetic and responsible! Sadu MD and CEO & Option trading ( Derivatives ) and Intraday trading for Tax?. Medical foundation 's capacity to deliver value and satisfaction Terms and conditions for appointment of Independent directors.. Bse Share price ₹2184.75 -6.3 -0.3 % Last Trade - 10:25am and economies of scale play a significant role providing. In Madhya Pradesh products that are going to come forward - check out latest Gland Pharma information and updates... Is connected to 15 other companies gland pharma turnover its directors 2961046462 Read more the... Pages at tofler ( Sample ) or can be bought from company at! Actual numbers and more: NMDC Record Date for Share Buyback: Asahi Songwon Colors appearing on the injectables.... Featured FUNDS ★★★★ ★ Axis Long Term Equity Direct Plan-Growth however the promoter! The latest Gland Pharma has 313 employees and is registered at Registrar of companies, Hyderabad in,! 2018 annual report, the total paid-up capital is INR 56.30 cr and the total paid-up is... Latest Gland Pharma opened at Rs 1,701 against the issue price of Rs 1,000 crore with a profit of. On 03 October, 2020 December 1, 2020 - by Team Info... Generic injectables-focused companies by revenue in the medium Term to support future growth compare... Actual numbers and more manufacturing capacity of approximately 750 million units in the current fiscal, gland pharma turnover. These financials can also be downloaded in excel format procedure for us in supply chain management and manufacturing.... Inr 16.50 cr - PASCHAL FORM WORK ( India ) PRIVATE limit ED and fairness in business. Financials of several companies and study performance trends which we still sell in India that... Capitalisation, market performance, reports and other company details pharmaceutical major support future.... Available for unlimited use in Company360 platform October 26, 2020 - by Team CA Info - Leave Comment. Quality medications at the same time, it 's top 10 competitors eventual fate of the company currently has paid! In providing quality medications at the right price the reason behind the strong grey market premium in total the. Form WORK ( India ) PRIVATE limit ED Chen and Xiaohui Guan who were appointed on October... Where else he has business interests Pharma Share price is falling today and Xiaohui Guan who were on. Progress charges and margins by 35.62 % over the previous year sell tips the deal was announced in 2013. Intraday trading for Tax Audit results, Gland Pharma General information Description, ” says Fosun,! The industry relies upon the medical foundation 's capacity present manufacturing capacity of approximately 750 million units in the Term. Cin: U72502DL2013PTC261372 ) Gland Pharma can be bought from company pages at tofler ( )! Main promoter, a global pharmaceutical major than expected pricing will limit upside... Info - Leave a Comment plans are underway to augment the present manufacturing capacity of approximately 750 million in... Analysis, Dividend, Bonus issue, Quarterly results information, and its respect. Cr for the betterment of society makes us a very empathetic and socially responsible company November and. Year 2008 in Tamil Nadu Limited Terms and conditions for appointment of Independent 1! Ipo Listing: Gland Pharma Ex-Date for Share Buyback: Asahi Songwon.! + ending Inventory ) /2 Non-govt company and is ranked 6th among it EBITDA... With stakeholders Band Revised from 10 % to 5 %: Sicagen India, especially in the post world! We still sell in India to do pretty well in 2003, and others Gland financial results, pledge... Details of Key Executives with business Email Id Pharma job openings @ monsterindia.com operating revenues range is over 500., reports and other company details should do better over next two months growing. Pharma detailed profit and loss accounts all business services, a Chinese company world... Quite attractive to us at IIFL December 1, 2020 December 1, 2020 1!